PROGRESS Against Neglected Tropical Diseases

Total Page:16

File Type:pdf, Size:1020Kb

PROGRESS Against Neglected Tropical Diseases PROGRESS SHEET Significant progress towards the elimination and eradication of neglected tropical diseases has been made in the last decade. Development of public-private partnerships, drug donations from major pharmaceutical companies, increased country and international agency commitment, and effective intervention strategies have led to dramatic declines in rates of infection from these debilitating diseases. Over the last five years, neglected tropical diseases (NTDs)— Elimination Program for the Americas (Merck & Co.), a group of debilitating infectious diseases that contribute to Global Programme to Eliminate Lymphatic Filariasis extreme poverty—have been the focus of increased attention. (GlaxoSmithKline, Merck & Co.), International Trachoma Countries, supported by a variety of global initiatives, have Initiative (Pfizer), Children Without Worms (Johnson & made remarkable headway in combating NTDs—including Johnson), and the WHO Program to Eliminate Sleeping diseases such as leprosy, lymphatic filariasis (elephantiasis), Sickness (Bayer, sanofi-aventis) to provide treatment for those onchocerciasis (river blindness), schistosomiasis (snail fever), NTDs. For schistosomiasis control, praziquantel has been and trachoma—and guinea worm may be the next disease provided via WHO by Merck KGaA and by MedPharm to the eradicated from the planet. Schistosomiasis Control Initiative. Drugs for leprosy control are provided free by Novartis. Global Progress This collection of programs and alliances has been successful in bringing together partners to address NTDs, but there The prospects for reducing the enormous burden caused are others who also provide support to national programs by NTDs have changed dramatically in just the past few fighting these diseases. years, in part due to the growing recognition of the linkages between the fight against these debilitating diseases and The Carter Center spearheads efforts with theCenters for progress towards the United Nations Millennium Disease Control (CDC), WHO, and UNICEF to eradicate guinea Development Goals (MDGs). worm disease. This disease has been eliminated in all but six countries, and cases have been reduced by more than 99 The remarkable efforts of public-private partnerships under percent. The final battle to find and contain the last cases in the leadership of the World Health Organization (WHO)— the hardest-to-reach parts of the world is under way. which include the pharmaceutical industry, academic and research institutions, donors, nongovernmental organizations, Bilateral development agencies also contribute, including the and local communities—have revolutionized the treatment U.S. Agency for International Development (USAID) Neglected and control of many diseases. For example, when the Tropical Disease Control Program, which was established in Mectizan Donation Program was launched by Merck & Co. Inc. 2006 to reduce the burden of NTDs. USAID expanded efforts in 1987, collaboration between the public and private sectors in 2008, launching the Neglected Tropical Diseases Initiative in addressing global health challenges was uncommon. The which committed $350 million (2009–2013) to deliver program was initially established to oversee the donation of integrated NTD treatment to 300 million people in Africa, their drug Mectizan® (also known as ivermectin) “for as long Asia, and Latin America.1 as needed” to treat onchocerciasis, and was expanded to An improved understanding of the relationship between include lymphatic filariasis in 1998. Programs such as this one NTDs and extreme poverty has prompted other new initiatives. make it financially possible to provide the annual or biannual In addition to the MDGs, there are many international and drug doses required for treatment of these diseases to the regional goals which help spur action to improve health. millions of people at risk. For example, in 2001, WHO adopted a resolution to reduce Since then, pharmaceutical companies have donated billions parasitic worm infections by deworming 75 percent of all of doses of drugs to programs such as the African Program at-risk school-age children by 2010—the largest public health for Onchocerciasis Control and the Onchocerciasis program ever attempted. WHO’s Global Plan to Combat OCTOBER 2009 1 PROGRESS aGainst neglEcted tropical diseases NTDs has as its goal the prevention, access to medications and created the control, elimination, or eradication possibility of controlling some diseases GUinEa WORM of NTDs, particularly the elimination to the point of elimination: or eradication of a targeted group of ERadicaTiOn • Distribution of drugs to an entire diseases by 2015. PROGRESS 2 population, known as mass drug Declines in total number Promoting even greater awareness and administration (MDA), has allowed of cases since 1989 coordination is the Global Network for countries to significantly control 900 NUMBER OF CASES ( Neglected Tropical Diseases, an alliance onchocerciasis, lymphatic filariasis, 800 of international organizations working schistosomiasis, trachoma, and soil- 700 to control and eliminate NTDs by 2020, transmitted worms.5 An integrated 600 which launched in 2006. approach using a combination of four drugs can treat multiple 500 diseases at once.6 400 thousands innovation and 300 • Community-directed treatment Scientific advances 200 is a sustainable and cost-effective Development of innovative strategies 100 method of MDA, which was ) for the delivery of existing drugs and 0 developed by African researchers methods to encourage behavior change 1989 1995 2001 2007 for the distribution of ivermectin have allowed for continued progress in to treat onchocerciasis (river Source: World Health Organization controlling NTDs globally. blindness). This strategy empowers Significant efforts have been made communities to take responsibility to prevent trachoma using the SAFE for drug distribution and has costs, particularly by identifying Strategy, which was introduced delivered hundreds of millions of where the diseases overlap. by WHO in 1996. The strategy uses drug doses, as well as other health National research programs, WHO surgery to correct eyelid defects that interventions, often to populations and other international agencies, lead to blindness, antibiotics to treat with little access to health services.7 active infections, face washing, and and foundations are supporting • To assist in implementing interventions, research and development for “tool- environmental improvement (by researchers have developed rapid deficient” diseases, where existing providing clean water and sanitation) mapping techniques which allow drugs are inappropriate or diagnostic to prevent transmission of the bacteria for targeting of drug distribution and surveillance tools inadequate. that cause trachoma.4 programs and facilitate planning for Innovative nonprofit product New strategies for distributing drugs more integrated approaches. This development partnerships have to infected populations have increased enhances efficiency and reduces also emerged to fill the gaps. WHaT are neglEcted tropical diseases? More than 1 billion people—one-sixth of The following diseases are responsible for • Soil-transmitted helminth infections: the world’s population—suffer from one or 90 percent of the global NTD burden.3 Hookworm, Ascariasis (roundworm) and more NTDs, which can cause disfigurement, Trichuriasis (whipworm) are parasites • Lymphatic filariasis (elephantiasis) is disability, and even death. that are ingested in contaminated food a mosquito-borne parasitic infection. or water, or in the case of hookworm, NTDs are called neglected because People with the disease can suffer from exposure of the skin (often the feet) to they have been largely wiped out in the disfigurement and permanent disabilities larvae in contaminated soil. Infection can developed world and persist only in the where limbs or other parts of the body cause anemia and malnutrition, as well as poorest, most marginalized communities are grotesquely swollen or enlarged. and conflict zones. They thrive in places other more serious and/or fatal problems. • Onchocerciasis (river blindness) is a with unsafe water, poor sanitation, and • Trachoma is a bacterial eye infection, parasitic worm disease spread by the limited access to basic health care. which, if left untreated, leads to bite of infected black flies that causes irreversible and painful visual impairment The primary listing of NTDs includes 13 blindness and skin lesions. parasitic and bacterial tropical infections. and blindness. It is the world’s leading Each disease manifests differently but • Schistosomiasis (snail fever) is a parasitic cause of infectious blindness. worm disease transmitted by freshwater frequently impacts the same populations, The other NTDs which complete the hindering economic development, causing snails. It causes the highest mortality list of 13 are guinea worm disease, chronic disability, and impairing childhood among the NTDs, but can be treated by leishmaniasis, Chagas disease, human development. As a result, NTDs cause billions drug therapy, which reduces the severity African trypanosomiasis (sleeping sickness), of dollars in lost wages, keeping those at risk of lesions that result in chronic and life- Buruli ulcer, and leprosy. of infection trapped in a cycle of poverty. threatening disease. OCTOBER 2009 2 PROGRESS aGainst neglEcted tropical diseases Results South Korea, Solomon Islands, Sri Lanka, past two decades. China has also made Programs
Recommended publications
  • A Call to Support Francophone African
    KNOWLEDGE BRIEF Health, Nutrition and Population Global Practice A CALL TO SUPPORT FRANCOPHONE Public Disclosure Authorized AFRICAN COUNTRIES TO END THE TREMENDOUS SUFFERING FROM NTDs Gaston Sorgho, Fernando Lavadenz and Opope Oyaka Tshivuila Matala December 2018 KEY MESSAGES: • Eighteen Neglected Tropical Diseases (NTDs) and Malaria account together for 22% of the total burden of communicable diseases in 25 Francophone African Countries (FPACs). Public Disclosure Authorized • The cumulative impact of NTDs decreases the quality of life of households, slows economic growth and results in millions of dollars in lost economic productivity annually. For example, the World Bank (WB) estimates annual losses of US$33 million in Cameroon, US$13 million in Chad and US$9 million in Madagascar. • Of the 18 NTDs, 5 can be controlled by preventive chemotherapy (PC) through safe Mass Drug Administration (MDA). • In 2017, the WB launched the Deworming Africa Initiative (DAI), with the purpose of raising the profile of NTDs control and elimination efforts among endemic Sub-Saharan African (SSA) countries to eliminate NTDs as a public health threat. • DAI’s strategy seeks to reduce the burden of NTDs in 3 key population groups that mostly impact on human capital: young children (12-23 months), pregnant women, and school-age children (SAC) (5-14 years of age). To achieve this objective in a sustainable way, DAI supports Country efforts to strengthen the coordinated engagement of the health, education, water, sanitation and hygiene (WASH) and economic sectors with a national prevention and control strategy. • The WB's total annual investments in NTDs control have increased from US$3.3 million in 2013 to US$13.9 million in 2018.
    [Show full text]
  • CDC Overseas Parasite Guidelines
    Guidelines for Overseas Presumptive Treatment of Strongyloidiasis, Schistosomiasis, and Soil-Transmitted Helminth Infections for Refugees Resettling to the United States U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Division of Global Migration and Quarantine February 6, 2019 Accessible version: https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/intestinal- parasites-overseas.html 1 Guidelines for Overseas Presumptive Treatment of Strongyloidiasis, Schistosomiasis, and Soil-Transmitted Helminth Infections for Refugees Resettling to the United States UPDATES--the following are content updates from the previous version of the overseas guidance, which was posted in 2008 • Latin American and Caribbean refugees are now included, in addition to Asian, Middle Eastern, and African refugees. • Recommendations for management of Strongyloides in refugees from Loa loa endemic areas emphasize a screen-and-treat approach and de-emphasize a presumptive high-dose albendazole approach. • Presumptive use of albendazole during any trimester of pregnancy is no longer recommended. • Links to a new table for the Treatment Schedules for Presumptive Parasitic Infections for U.S.-Bound Refugees, administered by IOM. Contents • Summary of Recommendations • Background • Recommendations for overseas presumptive treatment of intestinal parasites o Refugees originating from the Middle East, Asia, North Africa, Latin America, and the Caribbean o Refugees
    [Show full text]
  • Rapid Screening for Schistosoma Mansoni in Western Coã Te D'ivoire Using a Simple School Questionnaire J
    Rapid screening for Schistosoma mansoni in western Coà te d'Ivoire using a simple school questionnaire J. Utzinger,1 E.K. N'Goran,2 Y.A. Ossey,3 M. Booth,4 M. TraoreÂ,5 K.L. Lohourignon,6 A. Allangba,7 L.A. Ahiba,8 M. Tanner,9 &C.Lengeler10 The distribution of schistosomiasis is focal, so if the resources available for control are to be used most effectively, they need to be directed towards the individuals and/or communities at highest risk of morbidity from schistosomiasis. Rapid and inexpensive ways of doing this are needed, such as simple school questionnaires. The present study used such questionnaires in an area of western Coà te d'Ivoire where Schistosoma mansoni is endemic; correctly completed questionnaires were returned from 121 out of 134 schools (90.3%), with 12 227 children interviewed individually. The presence of S. mansoni was verified by microscopic examination in 60 randomly selected schools, where 5047 schoolchildren provided two consecutive stool samples for Kato±Katz thick smears. For all samples it was found that 54.4% of individuals were infected with S. mansoni. Moreover, individuals infected with S. mansoni reported ``bloody diarrhoea'', ``blood in stools'' and ``schistosomiasis'' significantly more often than uninfected children. At the school level, Spearman rank correlation analysis showed that the prevalence of S. mansoni significantly correlated with the prevalence of reported bloody diarrhoea (P = 0.002), reported blood in stools (P = 0.014) and reported schistosomiasis (P = 0.011). Reported bloody diarrhoea and reported blood in stools had the best diagnostic performance (sensitivity: 88.2%, specificity: 57.7%, positive predictive value: 73.2%, negative predictive value: 78.9%).
    [Show full text]
  • Equine Recommended Deworming Schedule
    EQUINE FIELD SERVICE EQUINE RECOMMENDED DEWORMING SCHEDULE ADULT HORSE SCHEDULE n LOW SHEDDERS (<200 EPG – eggs per gram of manure) Fecal Egg Count performed prior to deworming in spring (ideally spring and fall) SPRING (March) – ivermectin (Equell®, Zimectrin®, Rotectin®, IverCare®), moxidectin (Quest®) FALL (October) – ivermectin w/praziquantel (Equimax®, Zimectrin Gold®) or moxidectin with praziquantel (Quest Plus®) n MODERATE SHEDDERS (200 – 500 EPG) Fecal Egg Count performed prior to deworming in spring (ideally spring and fall) SPRING (March) – Ivermectin (Equell®, Zimectrin®, Rotectin®, IverCare, etc), moxidectin (Quest®) or double-dose fenbendazole for 5 days (Panacur® PowerPak) LATE SUMMER (July) – pyrantel pamoate (Strongid paste®, TapeCare Plus®, etc), fenbendazole (Panacur®, Safe-Guard®) EARLY WINTER (November) – ivermectin w/praziquantel (Equimax®, Zimectrin Gold®) or moxidectin with praziquantel (Quest Plus®) n HIGH SHEDDERS (>500 EPG) Fecal Egg Count performed prior to deworming in spring and fall to monitor for signs of resistance SPRING (March) – ivermectin (Equell®, Zimectrin®, Rotectin®, IverCare®), moxidectin (Quest®) or double-dose of fenbendazole for 5 days (Panacur® PowerPak) SUMMER (June) – pyrantel pamoate (Strongid paste®, TapeCare Plus®), fenbendazole (Panacur, SafeGuard®) or Oxibendazole (Anthelcide®) FALL (September) – ivermectin w/ praziquantel (Equimax®, Zimectrin Gold®) or moxidectin with praziquantel (Quest Plus®) WINTER (December) – pyrantel pamoate (Strongid paste®, TapeCare Plus®), fenbendazole (Panacur®,
    [Show full text]
  • General Horse Care MP501
    MP501 General Horse Care DIVISION OF AGRICULTURE RESEARCH & EXTENSION University of Arkansas System University of Arkansas, United States Department of Agriculture, and County Governments Cooperating General Horse Care General Nutrition and Feeding Management ...............................................................................1 Determining the Amount to Feed ......................................................................................2 Selecting Grain and Hay ....................................................................................................3 Vaccinations ..................................................................................................................................5 Deworming ...................................................................................................................................6 Parasite Control via Manure Management .......................................................................7 Resisting Resistance .........................................................................................................7 Deworming Schedules ......................................................................................................7 Recognizing the Signs of Equine Colic ........................................................................................8 Preventing Barn Fires ...................................................................................................................9 Overview Mark Russell Instructor - Animal Science University
    [Show full text]
  • Performance of Two Serodiagnostic Tests for Loiasis in A
    Performance of two serodiagnostic tests for loiasis in a Non-Endemic area Federico Gobbi, Dora Buonfrate, Michel Boussinesq, Cédric Chesnais, Sébastien Pion, Ronaldo Silva, Lucia Moro, Paola Rodari, Francesca Tamarozzi, Marco Biamonte, et al. To cite this version: Federico Gobbi, Dora Buonfrate, Michel Boussinesq, Cédric Chesnais, Sébastien Pion, et al.. Perfor- mance of two serodiagnostic tests for loiasis in a Non-Endemic area. PLoS Neglected Tropical Dis- eases, Public Library of Science, 2020, 14 (5), pp.e0008187. 10.1371/journal.pntd.0008187. inserm- 02911633 HAL Id: inserm-02911633 https://www.hal.inserm.fr/inserm-02911633 Submitted on 4 Aug 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. PLOS NEGLECTED TROPICAL DISEASES RESEARCH ARTICLE Performance of two serodiagnostic tests for loiasis in a Non-Endemic area 1 1 2 2 Federico GobbiID *, Dora Buonfrate , Michel Boussinesq , Cedric B. Chesnais , 2 1 1 1 3 Sebastien D. Pion , Ronaldo Silva , Lucia Moro , Paola RodariID , Francesca Tamarozzi , Marco Biamonte4, Zeno Bisoffi1,5 1 IRCCS Sacro
    [Show full text]
  • Schistosomiasis Front
    Urbani School Health Kit TEACHER'S RESOURCE BOOK No Schistosomiasis For Me A Campaign on Preventing and Controlling Worm Infections for Health Promoting Schools World Health Urbani Organization School Health Kit Western Pacific Region Reprinted with support from: Urbani School Health Kit TEACHER'S RESOURCE BOOK No Schistosomiasis For Me A Campaign on the Prevention and Control of Schistosomiasis for Health Promoting Schools World Health Urbani Organization School Health Kit Western Pacific Region Urbani School Health Kit TEACHER'S RESOURCE BOOK page 1 What is schistosomiasis? What should children know about Schistosomiasis (or snail fever) is a disease common among residents (such as farmers, fisherfolk and their families) of communities where schistosomiasis? there they are exposed to infected bodies of water (such as irrigation systems, rice paddies, swamps). It is caused by worms (blood fluke) called Schistosoma japonicum that live in the intestines (particularly in the hepatic portal vein of the blood vessels) of infected persons. People get these worms by being exposed to waters where a type of tiny snail is present. The cercaria (or larva) that emerged from tiny snails can penetrate the skin submerged in the water. Once inside the body, the cercariae losses its tail and become schistosomula (the immature form of the parasite) that follows blood circulation, migrate to the blood vessels of the intestines and liver and cause illness. Schistosoma Japonicum The schistosomiasis worm has three distinct stages of development (see picture) during a lifetime, namely: (1) egg, (2) larva, and (3) worm. Egg: Persons who are infected with schistosomiasis will pass out worm Egg Larva Worm eggs through their feces.
    [Show full text]
  • Deworming Recommendations for Georgia 2014 Horner & Nash, DVM, PC
    Deworming Recommendations for Georgia 2014 Horner & Nash, DVM, PC In the past, veterinarians and parasitologists recommended a herd-based strategy which instructed owners to deworm every two months and to rotate between dewormers. Recent data, however, indicates that parasites are becoming resistant to our drugs and a more individualized approach is indicated based on bi-annual fecal egg counts. ADULT HORSES JANUARY 1. Submit a fecal sample from all horses to your veterinarian to ensure adequate control of parasites. DO THIS PRIOR TO TREATMENT! 2. Treat all horses with Moxidectin and Praziquantal (Quest Plus) Critical time of year to prevent strongyle egg shedding Moxidectin performs a larvidical deworming Cleans out bots and tapeworms ***Identify low, moderate or high egg shedders** Ensure to dose by your horse’s body weight **NOTE: It may be recommended that some extremely high egg shedders be dewormed with an Ivermectin first to decrease the adult worm load before the Moxidectin larvidical deworming is performed. This will be determined by your veterinarian from the fecal egg count results and previous history of deworming.** MARCH/APRIL 1. Submit a fecal sample to your veterinarian on moderate and high egg shedders 2. If treatment is needed then use Oxibendazole (Anthelcide) and Pyrantel Pamoate (Strongid). (If Ivermectin was used prior to Moxidectin/Praziquantal then no additional treatment is needed.) **NO further treatment is needed until September due to the heat and environment in Georgia** SEPTEMBER 1. Submit a fecal sample to your veterinarian to determine if your horse is a low, moderate or high egg shedder. DO THIS PRIOR TO TREATMENT! 2.
    [Show full text]
  • Conducting a School Deworming Day: a Manual for Teachers
    Conducting a school deworming day A manual for teachers WHO Library Cataloguing-in-Publication Data Conducting a school deworming day: a manual for teachers. 1.Parasitic diseases – prevention and control. 2.Helminths. 3.Child. 4.Schools. 5.Teaching materials. I.World Health Organization. ,6%1 1/0FODVVLÀFDWLRQ:& © World Health Organization 2013 $OOULJKWVUHVHUYHG3XEOLFDWLRQVRIWKH:RUOG+HDOWK2UJDQL]DWLRQDUHDYDLODEOHRQWKH:+2ZHEVLWH ZZZZKRLQW RUFDQEHSXUFKDVHGIURP:+23UHVV :RUOG+HDOWK2UJDQL]DWLRQ$YHQXH$SSLD*HQHYD6ZLW]HUODQG WHOID[HPDLOERRNRUGHUV#ZKRLQW 5HTXHVWVIRUSHUPLVVLRQWRUHSURGXFHRUWUDQVODWH:+2SXEOLFDWLRQV²ZKHWKHUIRUVDOHRUIRUQRQFRPPHUFLDOGLVWULEXWLRQ²VKRXOGEHDGGUHVVHGWR:+2 3UHVVWKURXJKWKH:+2ZHEVLWH ZZZZKRLQWDERXWOLFHQVLQJFRS\ULJKWBIRUPHQLQGH[KWPO 7KHGHVLJQDWLRQVHPSOR\HGDQGWKHSUHVHQWDWLRQRIWKHPDWHULDOLQWKLVSXEOLFDWLRQGRQRWLPSO\WKHH[SUHVVLRQRIDQ\RSLQLRQZKDWVRHYHURQWKHSDUWRIWKH :RUOG+HDOWK2UJDQL]DWLRQFRQFHUQLQJWKHOHJDOVWDWXVRIDQ\FRXQWU\WHUULWRU\FLW\RUDUHDRURILWVDXWKRULWLHVRUFRQFHUQLQJWKHGHOLPLWDWLRQRILWVIURQWLHUV RUERXQGDULHV'RWWHGOLQHVRQPDSVUHSUHVHQWDSSUR[LPDWHERUGHUOLQHVIRUZKLFKWKHUHPD\QRW\HWEHIXOODJUHHPHQW 7KHPHQWLRQRIVSHFLÀFFRPSDQLHVRURIFHUWDLQPDQXIDFWXUHUV·SURGXFWVGRHVQRWLPSO\WKDWWKH\DUHHQGRUVHGRUUHFRPPHQGHGE\WKH:RUOG+HDOWK 2UJDQL]DWLRQLQSUHIHUHQFHWRRWKHUVRIDVLPLODUQDWXUHWKDWDUHQRWPHQWLRQHG(UURUVDQGRPLVVLRQVH[FHSWHGWKHQDPHVRISURSULHWDU\SURGXFWVDUH distinguished by initial capital letters. $OOUHDVRQDEOHSUHFDXWLRQVKDYHEHHQWDNHQE\WKH:RUOG+HDOWK2UJDQL]DWLRQWRYHULI\WKHLQIRUPDWLRQFRQWDLQHGLQWKLVSXEOLFDWLRQ+RZHYHUWKHSXEOLVKHG PDWHULDOLVEHLQJGLVWULEXWHGZLWKRXWZDUUDQW\RIDQ\NLQGHLWKHUH[SUHVVHGRULPSOLHG7KHUHVSRQVLELOLW\IRUWKHLQWHUSUHWDWLRQDQGXVHRIWKHPDWHULDOOLHVZLWK
    [Show full text]
  • Personal View a Call to Strengthen the Global Strategy Against Schistosomiasis and Soil-Transmitted Helminthiasis
    Personal View A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now Nathan C Lo, David G Addiss, Peter J Hotez, Charles H King, J Russell Stothard, Darin S Evans, Daniel G Colley, William Lin, Jean T Coulibaly, Amaya L Bustinduy, Giovanna Raso, Eran Bendavid, Isaac I Bogoch, Alan Fenwick, Lorenzo Savioli, David Molyneux, Jürg Utzinger, Jason R Andrews Lancet Infect Dis 2016 In 2001, the World Health Assembly (WHA) passed the landmark WHA 54.19 resolution for global scale-up of mass Published Online administration of anthelmintic drugs for morbidity control of schistosomiasis and soil-transmitted helminthiasis, which November 29, 2016 affect more than 1·5 billion of the world’s poorest people. Since then, more than a decade of research and experience has http://dx.doi.org/10.1016/ S1473-3099(16)30535-7 yielded crucial knowledge on the control and elimination of these helminthiases. However, the global strategy has Division of Infectious Diseases remained largely unchanged since the original 2001 WHA resolution and associated WHO guidelines on preventive and Geographic Medicine chemotherapy. In this Personal View, we highlight recent advances that, taken together, support a call to revise the global (N C Lo BS, J R Andrews MD), strategy and guidelines for preventive chemotherapy and complementary interventions against schistosomiasis and soil- and Division of Epidemiology, transmitted helminthiasis. These advances include the development of guidance that is specific to goals of morbidity Stanford University School of Medicine, Stanford, CA, USA control and elimination of transmission. We quantify the result of forgoing this opportunity by computing the yearly (N C Lo); Children Without disease burden, mortality, and lost economic productivity associated with maintaining the status quo.
    [Show full text]
  • School Deworming at a Glance
    School Deworming at a glance Worms infect more than one third of the world’s There is no need to examine each child for the population, with the most intense infections in presence of worms. Individual screening offers no children and the poor. In the poorest countries, safety benefits. And it is not cost-effective; it costs children are likely to be infected from the time they four to ten times more than the treatment itself. stop breast-feeding, and to be continually infected Regular deworming will help children avoid the worst and re-infected for the rest of their lives. Only rarely effects of infection even if there is no improvement in does infection have acute consequences for children. sanitation. Instead, the infection is long-term and chronic, and can negatively affect all aspects of a child’s develop- Why deworming in schools? ment: health, nutrition, cognitive development, learn- School-age children typically have the highest ing and educational access and achievement. intensity of worm infection of any age group. In Deworming is safe, easy and cheap addition, the most cost-effective way to deliver deworming pills regularly to children is through All the common worm infections in school-age schools because schools offer a readily available, children can be treated effectively with two single- extensive and sustained infrastructure with a skilled dose pills: one for all the common intestinal worms workforce that is in close contact with the community. (hookworms, roundworms, and whipworms) and the other for schistosomiasis (bilharzia).1 The treatment is With support from the local health system, teachers safe, even when given to uninfected children.
    [Show full text]
  • Mini-FLOTAC As an Alternative, Non-Invasive Diagnostic Tool For
    Catalano et al. Parasites Vectors (2019) 12:439 https://doi.org/10.1186/s13071-019-3613-6 Parasites & Vectors RESEARCH Open Access Mini-FLOTAC as an alternative, non-invasive diagnostic tool for Schistosoma mansoni and other trematode infections in wildlife reservoirs Stefano Catalano1,2* , Amelia Symeou1, Kirsty J. Marsh1, Anna Borlase1,2, Elsa Léger1,2, Cheikh B. Fall3, Mariama Sène4, Nicolas D. Diouf4, Davide Ianniello5, Giuseppe Cringoli5, Laura Rinaldi5, Khalilou Bâ6 and Joanne P. Webster1,2 Abstract Background: Schistosomiasis and food-borne trematodiases are not only of major public health concern, but can also have profound implications for livestock production and wildlife conservation. The zoonotic, multi-host nature of many digenean trematodes is a signifcant challenge for disease control programmes in endemic areas. However, our understanding of the epidemiological role that animal reservoirs, particularly wild hosts, may play in the transmission of zoonotic trematodiases sufers a dearth of information, with few, if any, standardised, reliable diagnostic tests avail- able. We combined qualitative and quantitative data derived from post-mortem examinations, coprological analyses using the Mini-FLOTAC technique, and molecular tools to assess parasite community composition and the validity of non-invasive methods to detect trematode infections in 89 wild Hubert’s multimammate mice (Mastomys huberti) from northern Senegal. Results: Parasites isolated at post-mortem examination were identifed as Plagiorchis sp., Anchitrema sp., Echinostoma caproni, Schistosoma mansoni, and a hybrid between Schistosoma haematobium and Schistosoma bovis. The reports of E. caproni and Anchitrema sp. represent the frst molecularly confrmed identifcations for these trematodes in defni- tive hosts of sub-Saharan Africa.
    [Show full text]